Fill out the form and get a free case evaluation today!
Name *Email *Phone *Have you or a loved one been diagnosed with Sickle Cell Disease?Did you or a loved one take Oxbryta as a treatment for Sickle Cell?Did you or a loved one experience any of the following complications while taking Oxbryta? (Select all that apply)Please provide any additional information about your potential case: *
Is Oxbryta Affecting You or a Loved One?
If you or a loved one were prescribed Oxbryta (voxelotor) to treat sickle cell disease and have experienced serious health complications, including vaso-occlusive crises (VOCs), stroke, organ failure, or even death, you may be entitled to financial compensation.
Oxbryta, approved by the FDA to treat sickle cell disease, was marketed as a treatment that could help increase oxygen levels in the blood and reduce sickle cell complications. However, recent findings and post-marketing studies revealed dangerous side effects that could worsen the condition.
What is Oxbryta?
Oxbryta was introduced as a breakthrough medication designed to help people with sickle cell disease by increasing the ability of hemoglobin to carry oxygen throughout the bloodstream. It aimed to reduce painful sickle cell crises by targeting the underlying genetic problem causing sickle cell disease.
However, post-marketing studies and reports revealed that Oxbryta may significantly increase the risk of vaso-occlusive crises (VOCs), stroke, organ failure, and other serious side effects. This has led to calls for legal action against the manufacturers of Oxbryta—Pfizer and Global Blood Therapeutics—for their failure to properly warn patients and healthcare providers about these risks.
